Use of biomarkers to investigate occupational and environmental lung disorders

Chest

Volumn 109, Issue 3 SUPPL., 1996, Pages 9S-12S

  Schulte, Paul A ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

CIGARETTE SMOKING; CONFERENCE PAPER; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNE RESPONSE; LUNG CANCER; LUNG FUNCTION TEST; OCCUPATIONAL EXPOSURE; OCCUPATIONAL LUNG DISEASE; PRIORITY JOURNAL; SPIROMETRY;

BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; OCCUPATIONAL DISEASES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0029984394     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.3_Supplement.9S     Document Type: Article

References (26)

1. Tockman MS, Gupta PK, Pressman NJ, et al. Biomarkers of pulmonary disease. In: Schulte PA, Perera FP, eds. Molecular epidemiology: principles and practices. San Diego: Academic Press, 1993; 443-65
2. Borm PJA. Biological markers and occupational lung disease: mineral dust-induced respiratory disorders. Exp Lung Res 1994; 20:457-70
3. Kramer BS, Srivastava S. Molecular biology in lung cancer prevention: from the bench to the bedside. In: Srivastava S, Lippman SM, Hong WK, et al, eds. Early detection of cancer: molecular markers. Armonk: Futura Publishing, 1994; 1-12
4. Morgan WKC. Epidemiology and occupational lung disease. In: Morgan WIC, Seaton A, eds. Philadelphia: WB Saunders, 1995; 82-110
5. Fitzgerald MX, Smith AA, Gaensler A. Evaluation of electronic spirometers. N Engl J Med 1973; 289:1283
6. Sobol BJ. The early detection of airway obstruction: another perspective. Am J Med 1976; 60:619-24
7. Oscherwitz M, Edlavitch SA, Baker TR, et al. Differences in pulmonary functions in various racial groups. Am J Epidemiol 1972; 96:319-27
8. Miller A, Thornton JC, Smith H Jr, et al. Spirometric 'abnormality' in a normal reference population: further analysis of 1971 Oregon survey. Am J Ind Med 1980; 1:55-68
9. Guboran E, Williams MK, Walfords J, et al. Circadian variation of FEV in staff workers. Br J Ind Med 1969; 26:121-25
10. Schulte PA, Perera FP. Validation. In: Schulte PA, Perera FP, eds. Molecular epidemiology: principles and practices. San Diego: Academic Press, 1993; 79-109
11. Schulte PA. The use of biological markers in occupational health research and practice. J Toxicol Environ Health, 1993; 40:359-366
12. Rothman R, Stewart WF, Schulte PA. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiol Biomarkers Prev 1995; 401-11
13. National Academy of Sciences. Biological markers in environmental health research. Environ Health Perspect 1987; 79:1-19
14. Perera FP, Weinstein IB. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J Chron Dis 1982; 35:581-600
15. National Research Council. Biologic markers in pulmonary toxicology. Washington, DC: National Academy Press, 1989
16. National Research Council. Human exposure assessment for airborne pollutants: advances and opportunities. Washington, DC: National Academy Press, 1991
17. National Research Council. Environmental epidemiology. Washington, DC: National Academy Press, 1991
18. Hulka BS, Wilcosky TC, Griffith JD. Biological markers in epidemiology. New York: Oxford University Press, 1990; I-236
19. Wagner GR, Attfield MD, Parker JE. Chest radiography in dust exposed miners: promise and problems potential and imperfections. Occup Med State of the Art Reviews 1993; 8:127-41
20. Lee LW, ed. Human tissue monitoring and specimen banking: opportunities for exposure assessment, risk assessment, and epidemiologic research. Environ Health Perspect 1995; 103(suppl 3):1-112
21. Perera FP, Santella R. Carcinogenesis. In: Schulte PA, Perera FP, eds. Molecular epidemiology: principles and practices. San Diego: Academic Press, 1993; 227-300
22. Van Schooten FJ, Hillebrand MJX, van Leeuwen FE, et al. Polycyclic aromatic hydrocarbon-DNA adducts in lung cancer patients. Carcinogenesis 1990; 11:1677-81
23. Tang DL, Chiampraserts Santella RM, Perera FP. Molecular epidemiology of lung cancer: carcinogen-DNA adducts GSTM1 and risk [abstract]. Annual Meeting of the American Association for Research, Toronto, April 1, 1995
24. Caporaso NE, Tucker MA, Hoover RN, et al. Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst 1990; 82:1264-72
25. Borm PJA, Meijers JMM, Swaen GMH. Molecular epidemiology of coal worker's pneumoconiosis: application to risk assessment of oxidant and monokine generation by mineral dusts. Exp Lung Res 1990; 16:57-71
26. Schins PF, Borm PJA. Serum procollagen type III peptide in coal workers pneumoconiosis: a 5-year follow-up study. Exp Lung Res 1994; 29:445-55